CORCEPT THERAPEUTICS INC Selling, General and Administrative Expense
CORCEPT THERAPEUTICS INC (CORT) reported Selling, General and Administrative Expense of $156.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2026-06-30 was $156.90M, a 51.08% increase year-over-year.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2026-03-31 was $145.36M, a 60.33% increase year-over-year.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2025-12-31 was $130.24M, a 56.21% increase year-over-year.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for the quarter ending 2025-09-30 was $123.98M, a 68.12% increase year-over-year.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for fiscal 2025 was $448.73M, a 60.08% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for fiscal 2024 was $280.32M, a 52.13% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for fiscal 2023 was $184.26M, a 20.55% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC selling, general and administrative expense for fiscal 2022 was $152.85M, a 24.92% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 167 month |
|---|---|---|---|---|---|
| 2026-06-30 | $156.90M 10-Q · filed 2026-07-29 | $302.25M 10-Q · filed 2026-07-29 | $432.49M derived: sum of 3 quarters · filed 2026-07-29 | $556.47M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | $145.36M 10-Q · filed 2026-04-30 | $275.59M derived: sum of 2 quarters · filed 2026-04-30 | $399.57M derived: sum of 3 quarters · filed 2026-04-30 | $503.42M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $130.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $254.21M derived: sum of 2 quarters · filed 2026-02-24 | $358.06M derived: sum of 3 quarters · filed 2026-07-29 | $448.73M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $123.98M 10-Q · filed 2025-11-04 | $227.83M derived: sum of 2 quarters · filed 2026-07-29 | $318.49M 10-Q · filed 2025-11-04 | $401.86M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $103.85M 10-Q · filed 2026-07-29 | $194.51M 10-Q · filed 2026-07-29 | $277.88M derived: sum of 3 quarters · filed 2026-07-29 | $351.63M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $90.66M 10-Q · filed 2026-04-30 | $174.03M derived: sum of 2 quarters · filed 2026-04-30 | $247.78M derived: sum of 3 quarters · filed 2026-04-30 | $314.71M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $83.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $157.12M derived: sum of 2 quarters · filed 2026-02-24 | $224.05M derived: sum of 3 quarters · filed 2026-02-24 | $280.32M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $73.75M 10-Q · filed 2025-11-04 | $140.68M derived: sum of 2 quarters · filed 2025-11-04 | $196.95M 10-Q · filed 2025-11-04 | $244.10M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $66.94M 10-Q · filed 2025-07-31 | $123.20M 10-Q · filed 2025-07-31 | $170.35M derived: sum of 3 quarters · filed 2026-02-24 | $215.62M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $56.27M 10-Q · filed 2025-05-05 | $103.42M derived: sum of 2 quarters · filed 2026-02-24 | $148.68M derived: sum of 3 quarters · filed 2026-02-24 | $191.96M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $47.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $92.41M derived: sum of 2 quarters · filed 2026-02-24 | $135.69M derived: sum of 3 quarters · filed 2026-02-24 | $184.26M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $45.26M 10-Q · filed 2024-10-30 | $88.54M derived: sum of 2 quarters · filed 2024-10-30 | $137.11M 10-Q · filed 2024-10-30 | $179.43M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $43.28M 10-Q · filed 2024-07-29 | $91.84M 10-Q · filed 2024-07-29 | $134.17M derived: sum of 3 quarters · filed 2025-02-26 | $169.33M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $48.56M 10-Q · filed 2024-05-01 | $90.89M derived: sum of 2 quarters · filed 2025-02-26 | $126.05M derived: sum of 3 quarters · filed 2025-02-26 | $163.86M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $42.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $77.49M derived: sum of 2 quarters · filed 2025-02-26 | $115.30M derived: sum of 3 quarters · filed 2025-02-26 | $152.85M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $35.16M 10-Q · filed 2023-11-01 | $72.98M derived: sum of 2 quarters · filed 2023-11-01 | $110.53M 10-Q · filed 2023-11-01 | $142.81M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $37.81M 10-Q · filed 2023-08-02 | $75.36M 10-Q · filed 2023-08-02 | $107.65M derived: sum of 3 quarters · filed 2024-02-15 | $138.18M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $37.55M 10-Q · filed 2023-05-03 | $69.83M derived: sum of 2 quarters · filed 2024-02-15 | $100.37M derived: sum of 3 quarters · filed 2024-02-15 | $130.40M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | $32.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $62.82M derived: sum of 2 quarters · filed 2024-02-15 | $92.85M derived: sum of 3 quarters · filed 2024-02-15 | $122.36M 10-K · filed 2024-02-15 | |
| 2021-09-30 | $30.53M 10-Q · filed 2022-11-03 | $60.56M derived: sum of 2 quarters · filed 2022-11-03 | $90.07M 10-Q · filed 2022-11-03 | $115.77M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $30.03M 10-Q · filed 2022-08-04 | $59.54M 10-Q · filed 2022-08-04 | $85.23M derived: sum of 3 quarters · filed 2023-02-28 | $111.76M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $29.51M 10-Q · filed 2022-05-05 | $55.20M derived: sum of 2 quarters · filed 2023-02-28 | $81.73M derived: sum of 3 quarters · filed 2023-02-28 | $107.30M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $25.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $52.22M derived: sum of 2 quarters · filed 2023-02-28 | $77.79M derived: sum of 3 quarters · filed 2023-02-28 | $105.33M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $26.52M 10-Q · filed 2021-11-03 | $52.09M derived: sum of 2 quarters · filed 2021-11-03 | $79.63M 10-Q · filed 2021-11-03 | $106.76M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-30 | $25.57M 10-Q · filed 2021-07-29 | $53.11M 10-Q · filed 2021-07-29 | $80.24M derived: sum of 3 quarters · filed 2022-02-15 | $104.48M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-31 | $27.54M 10-Q · filed 2021-05-06 | $54.67M derived: sum of 2 quarters · filed 2022-02-15 | $78.91M derived: sum of 3 quarters · filed 2022-02-15 | $103.50M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | $27.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $51.38M derived: sum of 2 quarters · filed 2022-02-15 | $75.97M derived: sum of 3 quarters · filed 2022-02-15 | $100.36M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $24.25M 10-Q · filed 2020-11-03 | $48.84M derived: sum of 2 quarters · filed 2020-11-03 | $73.23M 10-Q · filed 2020-11-03 | $94.78M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-06-30 | $24.59M 10-Q · filed 2020-08-04 | $48.98M 10-Q · filed 2020-08-04 | $70.54M derived: sum of 3 quarters · filed 2021-02-23 | $91.85M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2019-03-31 | $24.39M 10-Q · filed 2020-05-04 | $45.95M derived: sum of 2 quarters · filed 2021-02-23 | $67.26M derived: sum of 3 quarters · filed 2021-02-23 | $87.24M derived: sum of 4 quarters · filed 2021-02-23 | |
| 2018-12-31 | $21.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $42.87M derived: sum of 2 quarters · filed 2021-02-23 | $62.85M derived: sum of 3 quarters · filed 2021-02-23 | $81.29M 10-K · filed 2021-02-23 | |
| 2018-09-30 | $21.31M 10-Q · filed 2019-11-07 | $41.29M derived: sum of 2 quarters · filed 2019-11-07 | $59.73M 10-Q · filed 2019-11-07 | $76.52M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $19.98M 10-Q · filed 2019-08-01 | $38.42M 10-Q · filed 2019-08-01 | $55.22M derived: sum of 3 quarters · filed 2020-02-24 | $71.69M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $18.44M 10-Q · filed 2019-05-09 | $35.23M derived: sum of 2 quarters · filed 2020-02-24 | $51.71M derived: sum of 3 quarters · filed 2020-02-24 | $65.82M derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $33.27M derived: sum of 2 quarters · filed 2020-02-24 | $47.38M derived: sum of 3 quarters · filed 2020-02-24 | $62.42M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $16.47M 10-Q · filed 2018-11-02 | $30.58M derived: sum of 2 quarters · filed 2018-11-02 | $45.62M 10-Q · filed 2018-11-02 | $57.38M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $14.11M 10-Q · filed 2018-08-09 | $29.15M 10-Q · filed 2018-08-09 | $40.91M derived: sum of 3 quarters · filed 2019-02-26 | $51.84M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | $15.04M 10-Q · filed 2018-05-09 | $26.80M derived: sum of 2 quarters · filed 2019-02-26 | $37.73M derived: sum of 3 quarters · filed 2019-02-26 | $49.85M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2016-12-31 | $11.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $22.69M derived: sum of 2 quarters · filed 2019-02-26 | $34.81M derived: sum of 3 quarters · filed 2019-02-26 | $45.24M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $10.93M 10-Q · filed 2017-11-03 | $23.05M derived: sum of 2 quarters · filed 2017-11-03 | $33.48M 10-Q · filed 2017-11-03 | $42.34M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $12.12M 10-Q · filed 2017-08-02 | $22.55M 10-Q · filed 2017-08-02 | $31.41M derived: sum of 3 quarters · filed 2018-02-28 | $40.70M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $10.43M 10-Q · filed 2017-05-02 | $19.30M derived: sum of 2 quarters · filed 2018-02-28 | $28.59M derived: sum of 3 quarters · filed 2018-02-28 | $37.93M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $18.15M derived: sum of 2 quarters · filed 2018-02-28 | $27.50M derived: sum of 3 quarters · filed 2018-02-28 | $36.95M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $9.29M 10-Q · filed 2016-11-02 | $18.63M derived: sum of 2 quarters · filed 2016-11-02 | $28.09M 10-Q · filed 2016-11-02 | $36.13M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-06-30 | $9.34M 10-Q · filed 2016-08-03 | $18.80M 10-Q · filed 2016-08-03 | $26.84M derived: sum of 3 quarters · filed 2017-03-06 | $35.94M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2015-03-31 | $9.45M 10-Q · filed 2016-05-04 | $17.50M derived: sum of 2 quarters · filed 2017-03-06 | $26.60M derived: sum of 3 quarters · filed 2017-03-06 | $34.56M derived: sum of 4 quarters · filed 2017-03-06 | |
| 2014-12-31 | $8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $17.15M derived: sum of 2 quarters · filed 2017-03-06 | $25.11M derived: sum of 3 quarters · filed 2017-03-06 | $34.92M 10-K · filed 2017-03-06 | |
| 2014-09-30 | $9.10M 10-Q · filed 2015-11-06 | $17.07M derived: sum of 2 quarters · filed 2015-11-06 | $26.87M 10-Q · filed 2015-11-06 | $34.39M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $7.96M 10-Q · filed 2015-08-07 | $17.77M 10-Q · filed 2015-08-07 | $25.29M derived: sum of 3 quarters · filed 2016-03-10 | $32.47M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | $9.80M 10-Q · filed 2015-05-08 | $17.32M derived: sum of 2 quarters · filed 2016-03-10 | $24.50M derived: sum of 3 quarters · filed 2016-03-10 | $32.66M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2013-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $14.70M derived: sum of 2 quarters · filed 2016-03-10 | $22.86M derived: sum of 3 quarters · filed 2016-03-10 | $31.24M 10-K · filed 2016-03-10 | |
| 2013-09-30 | $7.18M 10-Q · filed 2014-11-07 | $15.34M derived: sum of 2 quarters · filed 2014-11-07 | $23.72M 10-Q · filed 2014-11-07 | $30.20M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-06-30 | $8.16M 10-Q · filed 2014-08-08 | $16.54M 10-Q · filed 2014-08-08 | $23.02M derived: sum of 3 quarters · filed 2015-03-13 | $28.72M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-03-31 | $8.38M 10-Q · filed 2014-05-12 | $14.87M derived: sum of 2 quarters · filed 2015-03-13 | $20.56M derived: sum of 3 quarters · filed 2015-03-13 | $26.31M derived: sum of 4 quarters · filed 2015-03-13 | |
| 2012-12-31 | $6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $12.18M derived: sum of 2 quarters · filed 2015-03-13 | $17.93M derived: sum of 3 quarters · filed 2015-03-13 | $25.41M 10-K · filed 2015-03-13 | |
| 2012-09-30 | $5.69M 10-Q · filed 2013-11-12 | $11.45M derived: sum of 2 quarters · filed 2013-11-12 | $18.93M 10-Q · filed 2013-11-12 | $22.21M derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-06-30 | $5.75M 10-Q · filed 2013-08-09 | $13.24M 10-Q · filed 2013-08-09 | $16.52M derived: sum of 3 quarters · filed 2014-03-14 | $19.73M derived: sum of 4 quarters · filed 2014-03-14 | |
| 2012-03-31 | $7.49M 10-Q · filed 2013-05-08 | $10.77M derived: sum of 2 quarters · filed 2014-03-14 | $13.98M derived: sum of 3 quarters · filed 2014-03-14 | $16.64M derived: sum of 4 quarters · filed 2014-03-14 | $68.07M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $6.49M derived: sum of 2 quarters · filed 2014-03-14 | $9.16M derived: sum of 3 quarters · filed 2014-03-14 | $11.33M 10-K · filed 2014-03-14 | |
| 2011-09-30 | $3.21M 10-Q · filed 2012-11-08 | $5.88M derived: sum of 2 quarters · filed 2012-11-08 | $8.05M 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $2.67M 10-Q · filed 2012-08-09 | $4.84M 10-Q · filed 2012-08-09 | |||
| 2011-03-31 | $2.17M 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | $8.49M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |